Normalized Pre-Tax Income: A company's income before income tax expense smoothed out by removing non-recurring items.
BetterLife Pharma Inc. (BETRF) had Normalized Pre-Tax Income of $-2.63M for the most recently reported fiscal year, ending 2025-01-31.
| Income Statement Financials | |
-- |
|
$-2.55M |
|
-- |
|
-- |
|
$3.63M |
|
$-3.63M |
|
$1.00M |
|
$-2.63M |
|
|
Normalized Pre-Tax Income |
$-2.63M |
$-2.63M |
|
$-2.63M |
|
$-2.63M |
|
$-2.63M |
|
$-3.63M |
|
$-3.63M |
|
123.87M |
|
123.87M |
|
$-0.02 |
|
$-0.02 |
|
| Balance Sheet Financials | |
$0.16M |
|
-- |
|
-- |
|
$0.16M |
|
$5.47M |
|
$0.04M |
|
$0.04M |
|
$5.50M |
|
$-5.34M |
|
$-5.34M |
|
$-5.34M |
|
129.57M |
|
| Cash Flow Statement Financials | |
$-1.47M |
|
-- |
|
$1.45M |
|
$0.03M |
|
$0.01M |
|
$-0.02M |
|
$1.49M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.03 |
|
-- |
|
-- |
|
-0.01 |
|
-0.12 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.47M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
49.20% |
|
49.20% |
|
-1609.99% |
|
49.53% |
|
$-0.04 |
|
$-0.01 |
|
$-0.01 |
|